The addition of succinate to the NEC group further upregulated iNOS protein expression (p < 0.05), whereas LY294002 treatment partially reversed this effect (p < 0.05 and Figure 8 a,b). The gene discussed is NOS2; the disease is necrotizing enterocolitis.